Xiao Ma Selected Research

peoniflorin

1/2020	Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases-A Mini Review.
1/2020	Mechanism of Paeoniflorin in the Treatment of Bile Duct Ligation-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology.
5/2017	Paeoniflorin attenuates ANIT-induced cholestasis by inhibiting apoptosis in vivo via mitochondria-dependent pathway.
5/2017	Paeoniflorin ameliorates cholestasis via regulating hepatic transporters and suppressing inflammation in ANIT-fed rats.
4/2016	Serum Metabolomic Profiling in a Rat Model Reveals Protective Function of Paeoniflorin Against ANIT Induced Cholestasis.
11/2015	Paeoniflorin ameliorates ANIT-induced cholestasis by activating Nrf2 through an PI3K/Akt-dependent pathway in rats.
12/2014	Paeoniflorin alleviates liver fibrosis by inhibiting HIF-1α through mTOR-dependent pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao Ma Research Topics

Disease

60	Neoplasms (Cancer) 06/2022 - 01/2006
26	Inflammation (Inflammations) 01/2022 - 09/2011
23	Infections 01/2022 - 04/2005
19	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 08/2003
15	Fibrosis (Cirrhosis) 01/2022 - 01/2006
15	Cholestasis 01/2021 - 01/2015
13	Insulin Resistance 05/2022 - 01/2006
12	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 11/2014
11	Leukemia 07/2021 - 08/2010
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 02/2009
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 03/2006
9	Necrosis 01/2022 - 05/2017
9	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2014
8	Hypertension (High Blood Pressure) 01/2022 - 10/2012
8	Diabetic Cardiomyopathies 01/2022 - 01/2006
8	Liver Diseases (Liver Disease) 01/2022 - 12/2014
8	Whooping Cough (Pertussis) 05/2021 - 03/2010
8	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2015
7	Carcinogenesis 01/2022 - 07/2012
7	Breast Neoplasms (Breast Cancer) 11/2021 - 01/2015
6	Non-alcoholic Fatty Liver Disease 05/2022 - 01/2013
6	Hematologic Neoplasms (Hematological Malignancy) 02/2022 - 02/2012
6	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2018
6	Heart Failure 01/2022 - 01/2013
6	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 06/2015
6	Tetanus 01/2021 - 03/2010
6	Stomach Neoplasms (Stomach Cancer) 01/2021 - 10/2015
6	Dehydration (Water Stress) 12/2019 - 11/2014
5	Bronchiolitis Obliterans Syndrome 04/2022 - 12/2017
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 10/2013
5	Esophageal Squamous Cell Carcinoma 01/2022 - 01/2014
5	Pancreatitis 09/2021 - 11/2017
5	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 12/2012
5	Philadelphia Chromosome 01/2021 - 03/2010
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 04/2015
5	Diphtheria 05/2019 - 03/2010
5	Liver Neoplasms (Liver Cancer) 10/2018 - 01/2016
5	Body Weight (Weight, Body) 04/2018 - 01/2006
5	Lung Neoplasms (Lung Cancer) 01/2018 - 01/2015
4	Osteosarcoma (Osteogenic Sarcoma) 06/2022 - 01/2018
4	Pain (Aches) 06/2022 - 01/2015
4	Thrombocytopenia (Thrombopenia) 12/2021 - 01/2019
4	Acute Promyelocytic Leukemia 12/2021 - 05/2014
4	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 05/2021 - 03/2006
4	Carcinoma (Carcinomatosis) 01/2021 - 02/2015
4	Alveolar echinococcosis 06/2020 - 02/2009
4	Shock 05/2020 - 01/2016
4	Hematologic Diseases (Blood Diseases) 04/2020 - 08/2003
4	Hepatitis 01/2020 - 01/2014

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2006
19	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2013
15	Therapeutic UsesIBA 01/2022 - 01/2013
15	Pharmaceutical PreparationsIBA 01/2022 - 06/2014
13	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2013
12	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 03/2006
11	CytokinesIBA 10/2021 - 10/2013
11	Insulin (Novolin)FDA Link 01/2021 - 01/2006
9	AntioxidantsIBA 01/2022 - 11/2014
9	Biological ProductsIBA 01/2021 - 12/2012
9	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 11/2015
9	AcidsIBA 11/2020 - 04/2007
8	VaccinesIBA 10/2021 - 06/2010
7	Interleukin-6 (Interleukin 6)IBA 02/2022 - 12/2012
7	Messenger RNA (mRNA)IBA 10/2021 - 01/2006
7	peoniflorinIBA 01/2020 - 12/2014
6	Long Noncoding RNAIBA 01/2022 - 01/2017
6	Caspase 3 (Caspase-3)IBA 01/2021 - 12/2012
6	CurcuminIBA 01/2019 - 11/2014
6	1-Naphthylisothiocyanate (1 Naphthylisothiocyanate)IBA 12/2018 - 01/2015
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2014 - 08/2003
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2013
5	FlavonoidsIBA 08/2021 - 02/2016
5	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 07/2021 - 02/2008
5	SteroidsIBA 01/2021 - 04/2012
5	Amino Acids FDA Link 01/2021 - 01/2016
5	EnzymesIBA 06/2020 - 01/2015
5	AntigensIBA 10/2015 - 08/2006
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2022 - 10/2018
4	SugarsIBA 05/2022 - 01/2017
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
4	AlkaloidsIBA 01/2022 - 11/2010
4	Mitogen-Activated Protein KinasesIBA 01/2022 - 03/2006
4	InterferonsIBA 12/2021 - 08/2015
4	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 07/2017
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 01/2018
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021 - 09/2011
4	CateninsIBA 01/2021 - 01/2017
4	Nonprescription Drugs (Patent Medicines)IBA 01/2021 - 01/2016
4	Decitabine FDA Link 01/2021 - 10/2013
4	Triglycerides (Triacylglycerol)IBA 12/2020 - 01/2006
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 08/2003

Therapy/Procedure

40	Therapeutics 06/2022 - 08/2003
35	Hematopoietic Stem Cell Transplantation 07/2021 - 08/2004
18	Transplantation 04/2022 - 02/2009
18	Drug Therapy (Chemotherapy) 01/2022 - 03/2006
9	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 01/2016
6	Stem Cell Transplantation 01/2022 - 08/2003
4	Radiotherapy 01/2022 - 02/2015
4	Cell Transplantation 10/2021 - 10/2013
4	Aftercare (After-Treatment) 01/2021 - 10/2013